Cargando…

Correlation Between Hemoglobin Levels and the Prognosis of First-Line Chemotherapy in Patients with Advanced Gastric Cancer

BACKGROUND: This retrospective study evaluated the prognostic significance of hemoglobin (Hb) levels in patients (pts) with unresectable locally advanced or metastatic gastric cancer who have not previously received chemotherapy. PATIENTS AND METHODS: We screened 249 pts with advanced gastric cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Qing, Yuan, Xing, Xu, Qi, Li, Jingjing, Chen, Lei, Ying, Jieer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423215/ https://www.ncbi.nlm.nih.gov/pubmed/32821167 http://dx.doi.org/10.2147/CMAR.S256074

Ejemplares similares

PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study
por: Wei, Qing, et al.
Publicado: (2020)

Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study
por: Wei, Qing, et al.
Publicado: (2021)

Correlations of Hemoglobin Level and Perioperative Blood Transfusion with the Prognosis of Gastric Cancer: A Retrospective Study
por: Wu, Gang, et al.
Publicado: (2017)

The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis
por: Ying, Jieer, et al.
Publicado: (2015)

The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study
por: Yin, Luxi, et al.
Publicado: (2018)

Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers
por: Xu, Xiaoqing, et al.
Publicado: (2022)

Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy
por: Sun, Zhiwei, et al.
Publicado: (2019)

The Correlation Between Computed Tomography Volumetry and Prognosis of Advanced Gastric Cancer Treated with Neoadjuvant Chemotherapy
por: Chen, Chao, et al.
Publicado: (2020)

Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II–III
por: Li, Jingjing, et al.
Publicado: (2020)

Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy
por: Duan, Xiao-Peng, et al.
Publicado: (2023)

Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer
por: YUAN, MEIQIN, et al.
Publicado: (2014)

Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy
por: Wang, Zhuo, et al.
Publicado: (2020)

S-1-Based Chemotherapy versus Capecitabine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Carcinoma: A Meta-Analysis
por: He, Ming-ming, et al.
Publicado: (2013)

Efficacy of Acupuncture and Moxibustion as a Subsequent Treatment after Second-Line Chemotherapy in Advanced Gastric Cancer
por: Zhang, Yong-jie, et al.
Publicado: (2020)

Combination Chemotherapy with 5-Fluorouracil and Heptaplatin as First-line Treatment in Patients with Advanced Gastric Cancer
por: Min, Young Joo, et al.
Publicado: (2004)

First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study
por: Satake, Hironaga, et al.
Publicado: (2017)

Outcomes of 596 Advanced Gastric Cancer Patients with Different Numbers of Chemotherapy Lines: The More Chemotherapy Lines, the Better Survival
por: Sun, Li, et al.
Publicado: (2020)

Cholinesterase is Associated With Prognosis and Response to Chemotherapy in Advanced Gastric Cancer
por: Bi, Yanzhi, et al.
Publicado: (2021)

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy
por: Faloppi, Luca, et al.
Publicado: (2016)

Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
por: Mashhadi, Mohammad Ali, et al.
Publicado: (2016)

New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy
por: Koo, Dong-Hoe, et al.
Publicado: (2021)

Third-line chemotherapy in advanced gastric cancer: A systematic review and meta-analysis
por: Zheng, Yu, et al.
Publicado: (2017)

First‐line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis
por: Liu, Tianshu, et al.
Publicado: (2022)

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
por: Kang, H J, et al.
Publicado: (2008)

Survival Outcomes Following Combination of First-Line Platinum-Based Chemotherapy with S-1 in Patients with Advanced Gastric Cancer
por: Koumarianou, Anna, et al.
Publicado: (2020)

Early Tumor–Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer
por: Kim, Ryul, et al.
Publicado: (2022)

Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy
por: Xu, Qi, et al.
Publicado: (2023)

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients
por: Tampellini, M, et al.
Publicado: (2006)

NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population
por: Chen, Xiaoying, et al.
Publicado: (2016)

Association between admission hemoglobin level and prognosis in patients with type 2 diabetes mellitus
por: Song, Hai-Ying, et al.
Publicado: (2021)

Analysis of Prognostic Factors and Design of Prognosis Model for Patients with Stage IV Gastric Cancer Following First-Line Palliative Chemotherapy
por: Zhou, Qiyin, et al.
Publicado: (2020)

Cost‐effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy as the first‐line treatment for advanced esophageal cancer
por: Ye, Zhuo‐Miao, et al.
Publicado: (2022)

Serum basic fibroblast growth factor and interleukin-1β predict the effect of first-line chemotherapy in patients with advanced gastric cancer
por: Zheng, Li, et al.
Publicado: (2023)

Correlation of serum leptin with levels of hemoglobin in hemodialysis
por: Rafieian-Kopaei, Mahmoud, et al.
Publicado: (2012)

Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer: a Bayesian network meta-analysis
por: Liu, Shu, et al.
Publicado: (2022)

Correlation Between Platelet and Hemoglobin Levels and Pathological Characteristics and Prognosis of Early-Stage Squamous Cervical Carcinoma
por: Li, Xiaowei, et al.
Publicado: (2015)

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis
por: Möhring, Christian, et al.
Publicado: (2021)

Clinicopathologic characteristics of resectable colorectal cancer with mismatch repair protein defects in Chinese population: Retrospective case series and literature review
por: Li, Jingjing, et al.
Publicado: (2020)

Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
por: Kim, Jin Won, et al.
Publicado: (2019)

First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
por: Chung, Hyun Cheol, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bt5brpm0okmc42lck02p3ho73t